COPENHAGEN, Denmark, Sept. 29, 2026 -- Breye Therapeutics ApS (Breye), a clinical-stage biopharmaceutical company developing oral therapeutics for the early treatment of retinal diseases, today announced the successful close of...
Jeff Collins to sit on the review panel for the Life Science Company Showcase Event at the North Carolina Biotechnology Center in Research Triangle Park, NC
News | 10. 15. 2008
